How effective is Luvox for Generalized Anxiety Disorder? (a real world drug study)
Summary:
Overall ratings: 3.3/5 Long term ratings: 3.7/5
This is a phase IV clinical study of how effective Luvox (fluvoxamine maleate) is for Generalized anxiety disorder and for what kind of people. The study is created by eHealthMe from 26 Luvox users and is updated continuously.
What is Luvox?
Luvox has active ingredients of fluvoxamine maleate. It is often used in obsessive-compulsive disorder. eHealthMe is studying from 13,440 Luvox users. Check the latest studies of Luvox.
What is Generalized anxiety disorder?
Generalized anxiety disorder (excessive, uncontrollable, unexplained and often irrational worry) is found to be associated with 766 drugs and 1,538 conditions by eHealthMe. Check the latest studies of Generalized anxiety disorder.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
26 people are studied for taking Luvox in Generalized anxiety disorder
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Luvox effectiveness for Generalized anxiety disorder (number of people):
Overall:
- not at all: 0
- somewhat: 6
- moderate: 9
- high: 8
- very high: 3
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 3
- high: 2
- very high: 1
Gender of people who take Luvox for Generalized anxiety disorder *:
- female: 57.69 %
- male: 42.31 %
Age of people who take Luvox for Generalized anxiety disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 3.85 %
- 20-29: 26.92 %
- 30-39: 26.92 %
- 40-49: 19.23 %
- 50-59: 19.23 %
- 60+: 3.85 %
Who find Luvox more effective for Generalized Anxiety Disorder?
Gender of people who take Luvox for Generalized anxiety disorder *:
- female: 54.55 %
- male: 45.45 %
Age of people who take Luvox for Generalized anxiety disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 9.09 %
- 20-29: 9.09 %
- 30-39: 27.27 %
- 40-49: 27.27 %
- 50-59: 27.27 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Luvox?
- You can start a phase IV clinical trial to monitor Luvox safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Ahmed AB, Radwan AM, Baddary HM, "Prevalence of Generalized Anxiety Disorder in Patients with Rheumatoid Arthritis and its Relationship with Disease Activity", The Egyptian Journal of Hospital Medicine, 2016 Jan .
- Ahmed AB, Radwan AM, Baddary HM, "Prevalence of Generalized Anxiety Disorder in Patients with Rheumatoid Arthritis and its Relationship with Disease Activity", The Egyptian Journal of Hospital Medicine, 2016 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Luvox (13,440 reports)
Treatments, associated drugs and conditions:
- Generalized anxiety disorder (31,281 reports)
How the study uses the data?
The study is based on fluvoxamine maleate (the active ingredients of Luvox) and Luvox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Allopurinol cause Renal Failure Chronic Aggravated? - a second ago
- Diabetes and Visual Impairment - 3 seconds ago
- Could Aranesp cause Haemolysis? - 5 seconds ago
- Chloraprep One-Step and Arava drug interactions for women aged 40-49 - 18 seconds ago
- Could Viibryd cause Head Injury? - 18 seconds ago
- Insulin Nordisk Mixtard vs. Amaryl, side effect and effectiveness comparison - 19 seconds ago
- Could Dapagliflozin cause Chest Pain? - 20 seconds ago
- Could Creon cause Jaundice - Yellow Skin? - 22 seconds ago
- Cosentyx and Wasting for Women aged 50-59 - 27 seconds ago
- Cosentyx and Muscle Wasting for Women aged 50-59 - 28 seconds ago